Wenjie Liu - Concepedia

Author

Wenjie Liu

General Hospital of Shenyang Military Region ORCID

Also Known As

Wen-Jie Liu, Wen-jie Liu, Wenjie Liu

Publications

448

Citations

H-Index

Concepts

All Affiliations

General Hospital of Shenyang Military Region Shenyang Pharmaceutical University Virginia Commonwealth University Hunter Holmes McGuire VA Medical Center China Pharmaceutical University

About

Wenjie Liu is an author at General Hospital of Shenyang Military Region specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	205
2	Biochemistry	2	2	89
3	Engineering	1	1	14
4	Health Sciences	1	1	15
5	Natural Sciences	1	1	74

Wenjie Liu

Publications

394

Citations

H-Index

Page 1

	Year	Citations
CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing Zheng Liu, Wenjie Liu, Wei Wang, Proceedings of the National Academy of Sciences	2023	84
Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease Wenwu Liu, Xin Liu, Liting Tian, European Journal of Medicinal Chemistry Inhibitory ActivityMedicinal ChemistryDerivativesBiochemistryMedicine	2021	74
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease Wenjie Liu, Limeng Wu, Wenwu Liu, European Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryNeurodegenerative DiseasesAlzheimer's DiseaseMedicine	2022	43
Icariin inhibits the growth of human cervical cancer cells by inducing apoptosis and autophagy by targeting mTOR/PI3K/AKT signalling pathway. Shenjiao Huang, Tingting Xie, Wenjie Liu PubMed	2020	27
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment Wenjie Liu, Liting Tian, Limeng Wu, Bioorganic Chemistry Disease TreatmentAlzheimer's DiseaseMedicineRational Drug DesignPharmacological Agent	2022	24
An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease Xin Liu, Lingyun Lai, Jiang-xia Chen, Neuropharmacology Neurodegenerative DiseasesSignal TransductionAlzheimer's DiseaseSignaling PathwayMedicine	2023	22
Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity Xiaofei Yu, Wenjie Liu, Shixian Chen, Journal for ImmunoTherapy of Cancer	2021	19
Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy Zheng Liu, Chunqing Guo, Swadesh K. Das, Cancer Research	2021	17
RETRACTED: Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease Nan Wang, Wenjie Liu, Lijun Zhou, ACS Omega	2022	17
The benzoate plant metabolite ethyl gallate prevents cellular- and vascular-lipid accumulation in experimental models of atherosclerosis Wenjie Liu, Jianmin Liu, Shu Xing, Biochemical and Biophysical Research Communications Vascular-lipid AccumulationMetabolic SyndromeOxysterolBiochemistryMedicine	2021	15

Page 1